RS59449B1 - Stabilizovani dezmopresin - Google Patents

Stabilizovani dezmopresin

Info

Publication number
RS59449B1
RS59449B1 RSP20191285A RS59449B1 RS 59449 B1 RS59449 B1 RS 59449B1 RS P20191285 A RSP20191285 A RS P20191285A RS 59449 B1 RS59449 B1 RS 59449B1
Authority
RS
Serbia
Prior art keywords
pharmaceutical composition
desmopressin
gum
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
Other languages
English (en)
Serbian (sr)
Inventor
Bong Sang Lee
Su-Jun Park
Jiyeong Han
Myeongcheol Kil
Min Seop Kim
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53510836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS59449(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of RS59449B1 publication Critical patent/RS59449B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RSP20191285 2014-06-16 2015-06-15 Stabilizovani dezmopresin RS59449B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020140073067A KR20150144209A (ko) 2014-06-16 2014-06-16 안정화된 데스모프레신 또는 이의 약학적으로 허용가능한 염을 함유 약학 조성물
EP15734080.3A EP3154516B1 (en) 2014-06-16 2015-06-15 Stabilized desmopressin
PCT/EP2015/063347 WO2015193246A1 (en) 2014-06-16 2015-06-15 Stabilized desmopressin

Publications (1)

Publication Number Publication Date
RS59449B1 true RS59449B1 (sr) 2019-11-29

Family

ID=53510836

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP20191285 RS59449B1 (sr) 2014-06-16 2015-06-15 Stabilizovani dezmopresin

Country Status (33)

Country Link
US (1) US20170128521A1 (cg-RX-API-DMAC10.html)
EP (1) EP3154516B1 (cg-RX-API-DMAC10.html)
JP (1) JP6615130B2 (cg-RX-API-DMAC10.html)
KR (2) KR20150144209A (cg-RX-API-DMAC10.html)
CN (1) CN106456706B (cg-RX-API-DMAC10.html)
AR (1) AR100850A1 (cg-RX-API-DMAC10.html)
AU (1) AU2015276247C1 (cg-RX-API-DMAC10.html)
CA (1) CA2951768C (cg-RX-API-DMAC10.html)
CL (1) CL2016003219A1 (cg-RX-API-DMAC10.html)
CO (1) CO2017000354A2 (cg-RX-API-DMAC10.html)
DK (1) DK3154516T3 (cg-RX-API-DMAC10.html)
EA (1) EA032834B1 (cg-RX-API-DMAC10.html)
ES (1) ES2751600T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20191746T1 (cg-RX-API-DMAC10.html)
HU (1) HUE045395T2 (cg-RX-API-DMAC10.html)
IL (1) IL249538A0 (cg-RX-API-DMAC10.html)
JO (1) JO3500B1 (cg-RX-API-DMAC10.html)
LT (1) LT3154516T (cg-RX-API-DMAC10.html)
MX (1) MX374540B (cg-RX-API-DMAC10.html)
MY (1) MY182781A (cg-RX-API-DMAC10.html)
NZ (1) NZ727388A (cg-RX-API-DMAC10.html)
PH (1) PH12016502527B1 (cg-RX-API-DMAC10.html)
PL (1) PL3154516T3 (cg-RX-API-DMAC10.html)
PT (1) PT3154516T (cg-RX-API-DMAC10.html)
RS (1) RS59449B1 (cg-RX-API-DMAC10.html)
SA (1) SA516380492B1 (cg-RX-API-DMAC10.html)
SG (2) SG10201811139UA (cg-RX-API-DMAC10.html)
SI (1) SI3154516T1 (cg-RX-API-DMAC10.html)
TN (1) TN2016000561A1 (cg-RX-API-DMAC10.html)
TW (1) TWI670070B (cg-RX-API-DMAC10.html)
UA (1) UA119776C2 (cg-RX-API-DMAC10.html)
WO (1) WO2015193246A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201608020B (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114432424B (zh) * 2021-12-27 2023-06-27 南通联亚药业股份有限公司 一种稳定的铝塑包装去氨加压素片剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE60307082D1 (de) * 2002-05-07 2006-09-07 Ferring Bv In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
WO2007083323A2 (en) * 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
CN100463674C (zh) * 2006-12-22 2009-02-25 江苏奥赛康药业有限公司 一种氯雷他定口腔速溶膜及其制备方法
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release
TW201422254A (zh) * 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物

Also Published As

Publication number Publication date
BR112016029417A2 (pt) 2017-08-22
HRP20191746T1 (hr) 2019-12-27
JP2017523955A (ja) 2017-08-24
WO2015193246A1 (en) 2015-12-23
US20170128521A1 (en) 2017-05-11
KR20170020450A (ko) 2017-02-22
DK3154516T3 (da) 2019-09-23
TWI670070B (zh) 2019-09-01
AU2015276247B2 (en) 2019-09-12
EA201692556A1 (ru) 2017-04-28
PH12016502527A1 (en) 2017-04-10
NZ727388A (en) 2021-07-30
PL3154516T3 (pl) 2020-08-10
CN106456706B (zh) 2020-07-14
AR100850A1 (es) 2016-11-02
SA516380492B1 (ar) 2021-02-03
TN2016000561A1 (en) 2018-04-04
JO3500B1 (ar) 2020-07-05
KR20150144209A (ko) 2015-12-24
ZA201608020B (en) 2020-05-27
JP6615130B2 (ja) 2019-12-04
KR102360656B1 (ko) 2022-02-09
CA2951768A1 (en) 2015-12-23
EP3154516B1 (en) 2019-09-04
SI3154516T1 (sl) 2019-11-29
HUE045395T2 (hu) 2019-12-30
CL2016003219A1 (es) 2017-06-30
MX374540B (es) 2025-03-06
PH12016502527B1 (en) 2017-04-10
SG10201811139UA (en) 2019-01-30
ES2751600T3 (es) 2020-04-01
UA119776C2 (uk) 2019-08-12
IL249538A0 (en) 2017-02-28
MY182781A (en) 2021-02-05
CO2017000354A2 (es) 2017-03-31
EP3154516A1 (en) 2017-04-19
CN106456706A (zh) 2017-02-22
SG11201609374YA (en) 2017-01-27
AU2015276247C1 (en) 2020-02-06
MX2016016635A (es) 2017-06-06
LT3154516T (lt) 2019-10-25
EA032834B1 (ru) 2019-07-31
PT3154516T (pt) 2019-12-05
CA2951768C (en) 2022-08-30
BR112016029417A8 (pt) 2021-06-29
TW201605464A (zh) 2016-02-16
AU2015276247A1 (en) 2017-02-02

Similar Documents

Publication Publication Date Title
AU2012214939B2 (en) Sildenafil-free base-containing film preparation and method for producing same
CN103260616B (zh) 对乙酰氨基酚的稳定化剂
RS63304B1 (sr) Oftalmološka vodena kompozicija
WO2016143708A1 (ja) 眼科用組成物
CN105125570A (zh) 一种含硫氰酸红霉素药物组合物及其制备方法
JP6615130B2 (ja) 安定化デスモプレシン
CN115969820B (zh) 一种孟鲁司特钠口腔溶膜剂及其制备工艺
CN102046173B (zh) 含加替沙星的水性液体、其制备和防止形成沉淀的方法
CN104203224A (zh) 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水性组合物
CN118714998A (zh) 包含2-[(4s)-8-氟-2-[4-(3-甲氧基苯基)哌嗪-1-基]-3-[2-甲氧基-5-(三氟甲基)苯基]-4h-喹唑啉-4-基]乙酸酯和钾离子的药物组合物
HK1235295B (en) Stabilized desmopressin
HK1235295A1 (en) Stabilized desmopressin
BR112016029417B1 (pt) Composição farmacêutica na forma de uma película de desintegração oral, seu método de preparação, e uso de gomas para aumentar sua estabilidade
CN106420613A (zh) 一种氟苯尼考胶束制剂及其制备方法
WO2019227746A1 (zh) 一种壳聚糖口服液及其制备方法
CN105451731A (zh) 含有经稳定化的2－氨基－3－(4－溴苯甲酰基)苯乙酸的水性组合物
HK1220393B (en) Aqueous composition containing stabilized 2-amino-3-(4-bromobenzoyl)phenylacetic acid
CN121059522A (zh) 一种盐酸溴己新口服溶液及其制备方法
CN120204159A (zh) 一种富马酸伏诺拉生掩味微丸及其制备方法
WO2016082413A1 (zh) 一种用于注射的右旋布洛芬药物组合物及其制备方法
CN102178646A (zh) 一种稳定的替加氟注射液及其制备方法
JP2005097264A (ja) 点鼻剤組成物